β˜…
β˜…
β˜…
πŸ‡ΊπŸ‡ΈπŸ’Š

Lemonaid Health Review: What You Actually Get

An established general telehealth service with GLP-1s advertised from $129/month β€” a competitive number, attached to a promotion and very little else in the way of published detail.

3.6 / 5.0Reviewed August 5, 2026
$129/mo
GLP-1s starting, promotional
Both
Brand & compounded
Online
Assessment-based intake
Not stated
Eligibility criteria

How we're paid: Some links on this site are affiliate links, and we earn a commission when readers sign up through them. Every figure below was taken from Lemonaid Health's own published pages on the date shown, and is listed with its source at the bottom of this review. Full disclosure β†’

Overview

Lemonaid Health is a general telehealth company operating across multiple conditions, with weight management as one service line. It identifies itself as Lemonaid Health Inc, based in San Francisco, delivering care through four LMND Medical Group entities in different states β€” a more conventional corporate structure disclosure than most competitors offer.

The GLP-1 lineup covers compounded tirzepatide, compounded semaglutide, a compounded tirzepatide microdosing option, and brand-name Zepbound vials. Pricing is advertised as "GLP-1s starting at $129/mo", described as a limited-time offer.

That $129 figure is competitive if it is an all-in number β€” it would sit below Mochi Health's roughly $178 all-in β€” but Lemonaid does not clarify whether a separate membership or consultation fee applies on top. Nor does it publish eligibility criteria, lab requirements, or which pharmacy compounds its medications. The process is described simply: complete an online assessment, medical team review, medicine delivered.

Medications Offered

Brand-name (FDA-approved)

  • β€’Zepbound vials (tirzepatide)

Compounded

  • β€’Compounded tirzepatide
  • β€’Compounded semaglutide
  • β€’Compounded tirzepatide microdosing

A compounded-led lineup with brand-name Zepbound vials as the FDA-approved option. Lemonaid also offers a tirzepatide microdosing product β€” dosing below approved titration schedules, which is not an FDA-approved approach and for which no clinical rationale is published on the pages we reviewed. We cover what the clinical evidence says about microdosing in a separate guide. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.

How the Program Works

Consultation process

Lemonaid describes a three-step process: complete an online assessment, medical team review, then medicine delivery. The marketing emphasises starting "online in minutes" and requesting an online consultation. Whether any video visit is involved is not stated.

Eligibility

Not published on the pages we reviewed.

Provider involvement

A medical team reviews your assessment before any prescription. Care is delivered through LMND Medical Group entities operating in different states. Clinician credentials and ongoing access are not detailed.

Lab requirements

Not stated on the pages we reviewed.

Pharmacy fulfillment

Not named on the pages we reviewed.

Shipping

Medicine is delivered following medical team review. Timelines and cold-chain packaging details are not published.

Support services

Not detailed on the pages we reviewed. No coaching program, curriculum, or dietitian access is described.

Insurance

Lemonaid markets the service as letting you "skip the waiting room and insurance hassles", which indicates a cash-pay model. No insurance billing or benefits assistance is described.

Pricing

Membership fee

Not clearly separated. Lemonaid advertises "GLP-1s starting at $129/mo" as a limited-time offer, without stating whether a membership or consultation fee applies on top of the medication price.

Medication / planPublished priceNotes
GLP-1s β€” advertised entryFrom $129/moDescribed as a limited-time offer
Compounded semaglutideNot separately publishedOffered
Compounded tirzepatideNot separately publishedOffered
Zepbound vialsNot publishedBrand-name option
Membership / consultation feeNot statedUnclear whether one applies

Prices as published by Lemonaid Health on August 5, 2026. Telehealth pricing changes often, and promotional first-month rates are common. Check the provider's own page before you commit. Because it is unclear whether the $129 is all-in or medication-only, we cannot state a reliable total monthly cost.

Cancellation, Refunds & Payment

Cancellation policy

Lemonaid links to a cancellation policy page, but the terms are not summarised on the pages we reviewed.

Refund policy

Not stated on the pages we reviewed.

HSA / FSA

Not stated on the pages we reviewed.

Insurance handling

Lemonaid markets the service as letting you "skip the waiting room and insurance hassles", which indicates a cash-pay model. No insurance billing or benefits assistance is described.

What We Like

A competitive advertised entry price

At $129/month, the headline sits between the $99 compounded leaders and mid-market options β€” and if it turns out to be all-in, it would undercut most of them.

Both compounded and brand-name pathways

Compounded semaglutide and tirzepatide alongside brand-name Zepbound vials means an insurance change or a clinical preference for an approved product does not require switching provider.

Clear corporate and clinical structure

Lemonaid identifies itself as Lemonaid Health Inc, based in San Francisco, delivering care through named LMND Medical Group entities by state. That is more corporate transparency than most competitors provide, and it tells you who is actually responsible for your care.

An established multi-condition telehealth operation

Weight management is one service line among several rather than a business built entirely around the GLP-1 boom. That generally means more mature infrastructure.

What We'd Improve

It is unclear what the $129 actually includes

Lemonaid does not state whether a membership or consultation fee sits on top of the medication price. Without that, the headline cannot be compared against Mochi's published $79 + $99, and we cannot tell you your real monthly cost.

The price is explicitly a limited-time offer

Lemonaid describes the $129 rate as promotional without publishing what it reverts to. Starting a long-term medication on an expiring promotion with no stated successor rate is a budgeting risk.

No published eligibility criteria

No BMI thresholds, no comorbidities, no exclusions. Compare Fridays, which publishes nine specific medical exclusions, or PlushCare, which publishes its clinical thresholds.

Microdosing offered without explanation

A compounded tirzepatide microdosing product is listed with no published clinical rationale. Sub-therapeutic GLP-1 dosing is not an FDA-approved approach and warrants an explanation from the seller.

Nothing on labs, pharmacies, shipping, or refunds

A cancellation policy is linked but not summarised, and everything else operational is unpublished.

Who It May Be Best For

Worth considering if you:

  • β€’Want a mid-priced compounded option from an established multi-condition telehealth company
  • β€’Want compounded and brand-name Zepbound available from one provider
  • β€’Value knowing which medical entity is actually delivering your care
  • β€’Are paying cash and want a fast, assessment-based intake

Probably not if you:

  • β€’Need to know your total monthly cost before enrolling
  • β€’Want a price that is not explicitly promotional
  • β€’Want published eligibility criteria or exclusions
  • β€’Are relying on insurance coverage
  • β€’Want coaching, nutrition support, or lab work included

Limitations of This Review

  • β€’We reviewed Lemonaid's published pages rather than enrolling, so we cannot assess clinician quality, response times, or fulfilment.
  • β€’We could not determine whether the advertised $129 is an all-in figure or medication-only, which prevents us from stating a reliable total cost or ranking Lemonaid confidently against competitors on price.
  • β€’Eligibility criteria, lab requirements, pharmacy partners, shipping details, and refund terms are all unpublished.
  • β€’The $129 rate is described as a limited-time offer with no stated successor price.

Alternatives

Our Verdict

3.6 / 5.0

Lemonaid Health is a competent, established telehealth operation with a competitive-looking GLP-1 price and better corporate transparency than most β€” naming the medical groups that actually deliver care is a small thing that few competitors bother with.

But we cannot tell you what it costs. "$129/mo" without saying whether a membership sits on top is not a price a reader can act on, and describing it as a limited-time offer with no stated successor rate compounds the problem. Mochi Health publishes $79 plus $99 and lets you do the arithmetic; Lemonaid does not.

The microdosing product is the other thing we would want explained. It appears here as it does at Fridays and Noom β€” offered without a published clinical rationale, for a dosing approach that is not FDA-approved.

Worth considering if the price turns out to be all-in and the promotional rate holds, both of which you should confirm in writing before enrolling. If you want to compare costs before handing over your details, providers that publish both halves of the bill make that possible and this one does not.

Frequently Asked Questions

How much does Lemonaid Health cost for GLP-1s?+

Lemonaid advertises "GLP-1s starting at $129/mo" and describes it as a limited-time offer. It does not state whether a membership or consultation fee applies on top of that figure, so we cannot confirm your total monthly cost. Ask before enrolling.

Does Lemonaid offer brand-name medication?+

Yes β€” Zepbound vials appear in the lineup alongside compounded tirzepatide and semaglutide. Zepbound pricing is not published.

Who actually provides the medical care?+

Lemonaid Health Inc, based in San Francisco, delivers care through four LMND Medical Group entities operating in different states. Naming the medical groups is more disclosure than most telehealth companies provide.

Does Lemonaid take insurance?+

The service is marketed around skipping "insurance hassles", which indicates a cash-pay model. No insurance billing or benefits assistance is described on the pages we reviewed.

What is the tirzepatide microdosing option?+

It uses doses below the approved titration schedule. Lemonaid lists it without publishing a clinical rationale or evidence base. Microdosing is not an FDA-approved dosing approach, and it is worth asking a prescriber to explain the reasoning before starting.

What is Lemonaid's cancellation policy?+

Lemonaid links to a cancellation policy page but does not summarise the terms on its main pages. Given that the advertised price is promotional, read that policy before you enrol.

Where These Facts Came From

Every price, medication, and policy above was read directly from these pages on August 5, 2026. Where a provider does not publish something, we say so rather than estimate it.

Compare This Against Every Other Provider

Side-by-side pricing, medication access, and support for the platforms we've reviewed.

Compare All Providers

πŸ‡ΊπŸ‡ΈMedical Disclaimer

Your health, your doctor. This review is information, not medical advice. We're researchers and reviewers, not clinicians. GLP-1 medications are prescription drugs that require physician oversight, and they aren't appropriate for everyone. Talk to your healthcare provider about whether this class of medication fits your health situation. Individual responses vary significantly. Reviewed August 5, 2026.

Enter your email for a chance to win.
No purchase necessary.

By entering you agree to receive email from us. Unsubscribe anytime. No purchase necessary. Official Rules.